Skip to main content

IOANNIS GRIVEAS

MD,PhD

Publications

  • 66. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?
    Nikolaos Papadopoulos1, Ioannis Griveas2, Eirini Sveroni1, Vasiliki Argiana1, Antonios Kalliaropoulos3, Beatriz Martinez-Gonzalez3 and Melanie Deutsch4
    Int J Artif Organs. 2018 Mar;41(3):168-170
  • 67. The relation of parathyroid hormone and hematologic parameters under erythropoetin administration in hemodialysis patients.
    Theodora Papachrysanthou, Maria Aktsiali, Ioannis Griveas, Christos Andriopoulos, Panagiotis Sitaras, George I. Lambrou
    Private Dialyis Unit “Nefroiatriki”
    JRPMS | September 2019 | Vol. 3, No. 3 | 106-112 106
  • 68. Treatment with cinacalcet in hemodialysis patients with severe secondary hyperparathyroidism influences bone mineral metabolism and anemia parameters.
    Maria Aktsiali, Theodora Papachrysanthou, Ioannis Griveas, Christos Andriopoulos, Panagiotis Sitaras, Ioannis K. Triantafyllopoulos, George I. Lambrou*
    Private Dialyis Unit “Nefroiatriki”
    Current Drug Therapy 2019, DOI: 10.2174/1574885514666190802144629
  • 69. Sucroferric oxyhydroxide: A novel phosphate binder for the management of mineral bone disease in dialysis patients
    Griveas I*, Sitaras P, Andriopoulos C and Aktsiali M
    Blood Heart Circ, Volume 3: 1-4, 2019
  • 70. Efficacy and Tolerability of oral sucrosomial iron in CKD patients with anaemia and its association with CKD progression parameters
    Ioannis Griveas
    417 Army Share Fund Hospital, Athens, Greece
    Blood Tranfusion 17, Supplement no 1, March 2019